219 related articles for article (PubMed ID: 26166232)
1. A New Alternative Drug With Fewer Adverse Effects in the Treatment of Sydenham Chorea: Levetiracetam Efficacy in a Child.
Şahin S; Cansu A
Clin Neuropharmacol; 2015; 38(4):144-6. PubMed ID: 26166232
[TBL] [Abstract][Full Text] [Related]
2. Chorea in a patient with cerebral palsy: treatment with levetiracetam.
Recio MV; Hauser RA; Louis ED; Radhashakar H; Sullivan KL; Zesiewicz TA
Mov Disord; 2005 Jun; 20(6):762-4. PubMed ID: 15747368
[TBL] [Abstract][Full Text] [Related]
3. Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease.
Zesiewicz TA; Sullivan KL; Hauser RA; Sanchez-Ramos J
Mov Disord; 2006 Nov; 21(11):1998-2001. PubMed ID: 16941461
[TBL] [Abstract][Full Text] [Related]
4. Levetiracetam in tardive dyskinesia: an open label study.
Konitsiotis S; Pappa S; Mantas C; Mavreas V
Mov Disord; 2006 Aug; 21(8):1219-21. PubMed ID: 16637037
[TBL] [Abstract][Full Text] [Related]
5. Acute and chronic corticosteroid treatment of ten patients with paralytic form of Sydenham's chorea.
Fusco C; Ucchino V; Frattini D; Pisani F; Della Giustina E
Eur J Paediatr Neurol; 2012 Jul; 16(4):373-8. PubMed ID: 22197452
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of levetiracetam in the treatment of Sydenham chorea.
Direk M; Epcacan S; Epcacan Z; Yildirim DD; Okuyaz C
Pediatr Int; 2020 Nov; 62(11):1264-1268. PubMed ID: 32445412
[TBL] [Abstract][Full Text] [Related]
7. [Carbamazepine in paroxysmal choreoathetosis in Sydenham's chorea].
Artigas Palláres J; Lorente Hurtado I
An Esp Pediatr; 1989 Jan; 30(1):41-4. PubMed ID: 2930082
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of levetiracetam in Huntington disease.
de Tommaso M; Di Fruscolo O; Sciruicchio V; Specchio N; Cormio C; De Caro MF; Livrea P
Clin Neuropharmacol; 2005; 28(6):280-4. PubMed ID: 16340384
[TBL] [Abstract][Full Text] [Related]
9. Levetiracetam in the treatment of paroxysmal kinesiogenic choreoathetosis.
Chatterjee A; Louis ED; Frucht S
Mov Disord; 2002 May; 17(3):614-5. PubMed ID: 12112221
[TBL] [Abstract][Full Text] [Related]
10. Levetiracetam-induced parkinsonism in a Huntington disease patient.
Zesiewicz TA; Sanchez-Ramos J; Sullivan KL; Hauser RA
Clin Neuropharmacol; 2005; 28(4):188-90. PubMed ID: 16062099
[TBL] [Abstract][Full Text] [Related]
11. Levetiracetam therapy for treatment of choreoathetosis in dyskinetic cerebral palsy.
Vles GF; Hendriksen JG; Visschers A; Speth L; Nicolai J; Vles JS
Dev Med Child Neurol; 2009 Jun; 51(6):487-90. PubMed ID: 19018837
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy of carbamazepine, haloperidol and valproic acid in the treatment of children with Sydenham's chorea: clinical follow-up of 18 patients.
Peña J; Mora E; Cardozo J; Molina O; Montiel C
Arq Neuropsiquiatr; 2002 Jun; 60(2-B):374-7. PubMed ID: 12131934
[TBL] [Abstract][Full Text] [Related]
13. A family with paroxysmal nonkinesigenic dyskinesia: genetic and treatment issues.
Szczałuba K; Jurek M; Szczepanik E; Friedman A; Milewski M; Bal J; Mazurczak T
Pediatr Neurol; 2009 Aug; 41(2):135-8. PubMed ID: 19589464
[TBL] [Abstract][Full Text] [Related]
14. An open-label, prospective study of levetiracetam in children and adolescents with Tourette syndrome.
Fernández-Jaén A; Fernández-Mayoralas DM; Muñoz-Jareño N; Calleja-Pérez B
Eur J Paediatr Neurol; 2009 Nov; 13(6):541-5. PubMed ID: 19211282
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.
Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131
[TBL] [Abstract][Full Text] [Related]
16. Language Impairment in Adolescents With Sydenham Chorea.
Harsányi E; Moreira J; Kummer A; Meira ZM; Cardoso F; Teixeira AL
Pediatr Neurol; 2015 Nov; 53(5):412-6. PubMed ID: 26296451
[TBL] [Abstract][Full Text] [Related]
17. Levetiracetam: an improvement of attention and of oral fluency in patients with partial epilepsy.
Piazzini A; Chifari R; Canevini MP; Turner K; Fontana SP; Canger R
Epilepsy Res; 2006 Mar; 68(3):181-8. PubMed ID: 16332430
[TBL] [Abstract][Full Text] [Related]
18. Levetiracetam induces a rapid and sustained reduction of generalized spike-wave and clinical absence.
Cavitt J; Privitera M
Arch Neurol; 2004 Oct; 61(10):1604-7. PubMed ID: 15477517
[TBL] [Abstract][Full Text] [Related]
19. Activity, tolerability and efficacy of levetiracetam on cerebellar symptoms in multiple sclerosis patients: a pilot kinematic study.
Solaro C; Brichetto G; Capello E; Abuarqub S; Sanguineti V
Eur J Neurol; 2008 Jun; 15(6):619-26. PubMed ID: 18474077
[TBL] [Abstract][Full Text] [Related]
20. Sydenham's chorea: clinical findings and comparison of the efficacies of sodium valproate and carbamazepine regimens.
Genel F; Arslanoglu S; Uran N; Saylan B
Brain Dev; 2002 Mar; 24(2):73-6. PubMed ID: 11891095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
